SCHEMBL28057641

SCHEMBL28057641

COc1ccc(CC[C@H]2Cc3cc(O)cc(O)c3C(=O)O2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.50
CYP1A1 P04798 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP1B1 Q16678 1/20 0.47
SLC5A1 P13866 1/20 0.45
SLC5A2 P31639 1/20 0.45
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45
THRB P10828 1/20 0.45
HTT P42858 1/20 0.45
BLM P54132 1/20 0.45
KMT2A Q03164 1/20 0.45
CBS P35520 1/20 0.43
CYP3A4 P08684 1/20 0.43
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CALM1 P0DP23 1/20 0.41
KIT P10721 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30330184 1.00 CYP19A1 (0.50) CYP19A1CYP1A1CYP1A2CYP1B1SLC5A1
SCHEMBL28286221 0.81 NPC1 (0.54) SLC5A1SLC5A2
SCHEMBL2188208 0.79 KDM4E (0.53) CYP19A1MAPTKDM4EGAASMN1; SMN2
SCHEMBL28721233 0.75 CYP19A1 (0.56) CYP19A1CYP1A1CYP1A2CYP1B1POLB
SCHEMBL6790873 0.74 CYP3A4 (0.51) POLBCYP3A4
SCHEMBL16430754 0.74 CYP19A1 (0.64) CYP19A1CYP1A2SMN1; SMN2
SCHEMBL177102 0.73 CYP26A1 (0.47) CYP19A1MAPTSMN1; SMN2CALM1
SCHEMBL18214339 0.70 CYP3A4 (0.78) CYP1A2POLBMAPTCYP3A4SMN1; SMN2
SCHEMBL3366271 0.69 OPRD1 (0.62) POLBMAPTKDM4EGAASMN1; SMN2
SCHEMBL2314134 0.69 OPRD1 (0.62) POLBMAPTKDM4EGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106038799-A Pharmaceutical composition capable of treating cervical cancer and preparation method of pharmaceutical composition 济南星懿医药技术有限公司 2016-10-26 CN disclosed
CN-106038823-A Pharmaceutical composition capable of treating breast cancer at advanced stage 济南星懿医药技术有限公司 2016-10-26 CN disclosed
CN-106038797-A Pharmaceutical composition for preventing and treating bladder cancer 济南星懿医药技术有限公司 2016-10-26 CN disclosed
CN-105663248-A Depression treating pharmaceutical composition 济南星懿医药技术有限公司 2016-06-15 CN disclosed
CN-105641219-A Pharmaceutical composition for treating depression 济南星懿医药技术有限公司 2016-06-08 CN disclosed
CN-105596426-A Pharmaceutical composition for treating schizophrenia JINAN XINGYI MED TECH CO LTD 2016-05-25 CN disclosed
CN-105560866-A Medicine composition for preventing and treating benign prostatic hyperplasia and preparation method thereof JINAN XINGYI MED TECH CO LTD 2016-05-11 CN disclosed
CN-105560486-A Pharmaceutical composition for treating schizophrenia JINAN XINGYI MED TECH CO LTD 2016-05-11 CN disclosed
CN-105535092-A Medicine composition for treating prostatic hyperplasia JINAN XINGYI MED TECH CO LTD 2016-05-04 CN disclosed
CN-105535042-A Medicine composition for treating benign prostatic hyperplasia JINAN XINGYI MED TECH CO LTD 2016-05-04 CN disclosed
CN-105535226-A Medicine composition for treating esophagus cancer and preparation method thereof JINAN XINGYI MED TECH CO LTD 2016-05-04 CN disclosed